New scanner could halve repeat breast cancer surgeries
NCT ID NCT07527468
First seen Apr 17, 2026 · Last updated Jun 20, 2026 · Updated 8 times
Summary
This study tests a special scanner that lets surgeons check, in real time during breast cancer surgery, whether all cancer has been removed. The goal is to reduce the need for a second operation. About 228 women with certain high-risk breast cancer types will take part. The scanner is already approved for use, and this study will see if it cuts the repeat surgery rate from about 11% to 5% or less.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre Hospitalier du Valais Romand (CHVR)
Sion, Valais, 1950, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Histolog Scanner (a confocal fluorescence microscopy device used during surgery to check if all cancer has been removed)
What this could lead to
If successful, this device could help surgeons remove all cancer in one operation, reducing the need for a second surgery and its associated stress and recovery time.
What could go wrong
This is a relatively small, single-center study comparing results to past cases, not a randomized trial. The device may not work as well in all patients or tumor types, and the final decision for reoperation is made independently, so the device's impact may be limited.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.